These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23986042)

  • 21. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Established and emerging therapies for hepatocellular carcinoma.
    Cicinnati VR; Sotiropoulos GC; Beckebaum S
    Minerva Med; 2010 Dec; 101(6):405-18. PubMed ID: 21196900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostics and treatment of hepatocellular carcinoma. Recommendations of the Portal Hypertension Working Group of the Czech Hepatology Society and the J.E. Purkinje Czech Medical Society ].
    Brůha R; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka J; Spicák J; Vanásek T; Volfová M; Zdenek P;
    Vnitr Lek; 2005 Dec; 51(12):1406-8. PubMed ID: 16430109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can hepatocellular cancer screening increase the proportion of long-term survivors?
    Gannon CJ; Izzo F; Aloia TA; Pignata S; Nasti G; Vallone P; Orlando R; Scordino F; Curley SA
    Hepatogastroenterology; 2009; 56(93):1152-6. PubMed ID: 19760960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
    Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and therapeutic management of hepatocellular carcinoma.
    Bellissimo F; Pinzone MR; Cacopardo B; Nunnari G
    World J Gastroenterol; 2015 Nov; 21(42):12003-21. PubMed ID: 26576088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of hepatocellular carcinoma.
    Omata M; Yoshida H
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S111-4. PubMed ID: 14762850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R; Yoshida H; Tateishi R; Shiina S; Omata M
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1137-51. PubMed ID: 19187872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatocellular carcinoma - current aspects of screening, surveillance and therapeutic strategies (revised EASL-EORTC recommendations)].
    Roeb E
    Zentralbl Chir; 2014 Apr; 139(2):175-83. PubMed ID: 24132679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
    Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
    J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma.
    Wong JS; Wong GL; Tsoi KK; Wong VW; Cheung SY; Chong CN; Wong J; Lee KF; Lai PB; Chan HL
    Aliment Pharmacol Ther; 2011 May; 33(10):1104-12. PubMed ID: 21488914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBV-related HCC, clinical issues and therapy.
    Iavarone M; Colombo M
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S32-9. PubMed ID: 21195370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
    Hayashi PH; Di Bisceglie AM
    Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited hepatocellular carcinoma.
    Villanueva A; Newell P; Hoshida Y
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.